# Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

> **NCT06153433** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 112 (estimated)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Rosuvastatin Immediate-Release Tablet (IRT) 10mg
- **DRUG:** Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg

## Key facts

- **NCT ID:** NCT06153433
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-06
- **Primary completion:** 2024-07
- **Final completion:** 2024-08
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06153433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06153433, "Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06153433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*